	[Adherence to lung cancer screening by low-dose chest CT: Results of the first round of screening in the Multicenter Interventional DeCanPHaR Study]. Rev Mal Respir Strentz P, Rinaldo F, Jacquet-Pierroulet C, Baumann E, Fonne S, Bizot C, Hammas K, Palpacuer C, Debieuvre D, Decanphar Study Group. PMID: 41826137 [PubMed - as supplied by publisher]
	Lung cancer as a global health challenge: Multidimensional biomarker research and therapeutic advances. Int J Cancer Jin D, Zhong L, Chen L. PMID: 41826059 [PubMed - as supplied by publisher]
	Blood Based Biomarkers for Predicting Treatment Response to Immune Checkpoint Inhibitors After EGFR-TKI Resistance in Non-Small Cell Lung Cancer. Thorac Cancer Park MS, Lim JH, Park N, Park E, Lim A, Lee S, Cho Y, Kwak S, Lee M, Seo D, Kim L, Ryu WK, Ryu JS, Kim EY, Hong SS, Jung KH. PMID: 41825931 [PubMed - indexed for MEDLINE]
	Bridging FDA Adverse Event Reporting System (FAERS) and Clinical Practice: Comprehensive Characterization of Immune Checkpoint Inhibitors Toxicities in Geriatric Lung Cancer Patients. Thorac Cancer Tian Y, Nie X, Yuan Y, Wei Q, Zhang S, Li L. PMID: 41825930 [PubMed - indexed for MEDLINE]
	Randomised trial of delivering co-located, personalised stop-smoking support within lung cancer screening: the YESS study. Thorax Murray RL, Baldwin D, Brain K, Britton J, Chalitsios CV, Crosbie PA, Lewis S, McCutchan G, Steve P, Quaife S, Thorley R, Wu Q, Ashurst A, Beeken RJ, Copeland H, Gabe R, Hancock N, Marshall CS, Neal RD, Porter LR, Rogerson S, Quinn-Scoggins HD, Simmonds I, Sloss A, Callister MEJ. PMID: 41825863 [PubMed - as supplied by publisher]
	Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial. Lancet Oncol Zhong H, Wang J, Yang R, Luo Y, Zuo W, Zhang W, Xie C, Li Q, Liu Q, Xu X, Wang Q, Yu Y, Chen Y, Yi T, Min X, Shi J, Yang J, Sun H, Chen H, Shi H, Gao J, Shi J, Zhang B, Chu T, Li K, Han B, CAMPASS Investigators. PMID: 41825453 [PubMed - as supplied by publisher]
	EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world study. Lung Cancer Lin SH, Kahangire DA, Nagar SP, Ahn MJ, Affi R, Agulnik J, Shih JY, Hochmair MJ, Tufman A, Debieuvre D, Chow J, Jimenez M, Davis KL, Sandelin M, Veluswamy RR. PMID: 41825181 [PubMed - as supplied by publisher]
	Anlotinib + Toripalimab maintenance in Extensive-Stage small cell lung Cancer: Clinical efficacy and preclinical mechanism of anlotinib-induced neuroendocrine differentiation Suppression via Notch1. Lung Cancer Lv D, Zhu R, Wu G, Zhang Y, Pan W, Xu H, Wang Z, Yu Y, Yan S, Zhou C, Lin L, Lin W, Chen M, Wang Y, Bao Q, Ji X, You G, Zhu J, Huang J, He S, Wu X, Chen G. PMID: 41825180 [PubMed - as supplied by publisher]
	Immunotherapy rechallenge in Extensive-Stage small cell lung Cancer: A Real-World retrospective study. Lung Cancer Wang J, Zhong Y, Chen B, Xu Y, Xu L, Li J, Xu F, Wang Q, Li K, Kong Y, Liu L, Peng M, Liang Y, Wu L. PMID: 41825179 [PubMed - as supplied by publisher]
	Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer. Sci Adv Luvisotto A, Tulaiha R, Wang L. PMID: 41824576 [PubMed - indexed for MEDLINE]
	The early diagnostic value of lung cancer autoantibodies and tumor markers in lung cancer. Clin Transl Oncol Hao Y, Wang P, Zhao Z, Cheng J. PMID: 41824177 [PubMed - as supplied by publisher]
	Laryngeal ALK Positive Histiocytosis: Potential Mimic of Inflammatory Myofibroblastic Tumor-Case Report and Literature Review. Head Neck Pathol Kwon I, Sassoon J, Mori M, Brandwein-Weber M. PMID: 41824143 [PubMed - indexed for MEDLINE]
	Xenogeneic Collagen-Based Dural Substitute, A Stranger in Sinonasal Pathology. Head Neck Pathol Rosario SA, Lei L. PMID: 41824137 [PubMed - indexed for MEDLINE]
	The clinicopathologic characteristics and outcomes of uncommon KRAS mutations in patients with non-small cell lung cancer. Virchows Arch Zhang Y, Zhao J, Gao Q, Kong M. PMID: 41824068 [PubMed - as supplied by publisher]
	Multidisciplinary management of endobronchial carcinoid tumours through a combined bronchoscopic and surgical approach. Multimed Man Cardiothorac Surg Ayasa L, Swenson K, de Angelis P, Mubashir M, Kopach P, Majid A, Gangadharan S, Wilson J. PMID: 41823040 [PubMed - indexed for MEDLINE]
	A Meta-Analysis on the Incidence and Associated Factors of Pulmonary Fungal Infections in Lung Cancer Patients: Evidence Predominantly From Chinese Studies in the Chinese and English Literature. Thorac Cancer Deng L, Yu R, Chen B. PMID: 41822960 [PubMed - indexed for MEDLINE]
	Perioperative EGFR-Targeted Therapy in Resectable EGFR-Mutated NSCLC: A Narrative Review from Drug Design to Pain-Informed MRD-Guided Care. Drug Des Devel Ther Xiong L, Yang X, Yuan H, Qin L, Lin B, Chen F, Wen Y. PMID: 41822907 [PubMed - indexed for MEDLINE]
	A 12-gene immune signature predicts prognosis and identifies KRT6B as a therapeutic target in lung adenocarcinoma. Front Immunol Gu W, Wu Y, Jiang R, Shi M, Qi J, Lai J. PMID: 41822495 [PubMed - indexed for MEDLINE]
	Pulmonary infection by Nocardia saintgeorgesii mimicking lung cancer with concurrent pulmonary embolism in an immunocompetent host: a case highlighting the diagnostic role of mNGS. Front Cell Infect Microbiol Hu H, Cai D, Li J, Wang K. PMID: 41822328 [PubMed - indexed for MEDLINE]
	Targeted therapies in lung cancer: personalizing treatment across the age spectrum. Front Oncol Xu Y, Chen F, Zhang H, Wang X. PMID: 41821888 [PubMed]

Articles 1 - 20 / 157150

Page 1 of 7858



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy